Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) Return on Sales (2024 - 2026)

Beta Bionics' Return on Sales history spans 3 years, with the latest figure at 0.01% for Q1 2026.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.01% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.01%, a 0.0% change, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Sales hit 0.01% in Q1 2026 for Beta Bionics, down from 0.0% in the prior quarter.
  • Over the last five years, Return on Sales for BBNX hit a ceiling of 0.0% in Q4 2025 and a floor of 0.01% in Q1 2025.
  • Historically, Return on Sales has averaged 0.01% across 3 years, with a median of 0.01% in 2024.
  • The widest YoY moves for Return on Sales: up 0bps in 2025, down 0bps in 2025.
  • Tracing BBNX's Return on Sales over 3 years: stood at 0.01% in 2024, then grew by 29bps to 0.0% in 2025, then crashed by -89bps to 0.01% in 2026.
  • Business Quant data shows Return on Sales for BBNX at 0.01% in Q1 2026, 0.0% in Q4 2025, and 0.01% in Q3 2025.